Carfilzomib is derived from epoxomicin, a natural product that was shown by the laboratory of Craig Crews at Yale University to inhibit the proteasome. It is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.. Reference standards of Carfilzomib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => [(1S)-3-Methyl-1-[[(2S)-2-methyloxiranyl]carbonyl]butyl]-carbamic Acid 1,1-Dimethylethyl Ester [catalogue_number] => PA 30 63600 [category_ids] => ,79,84, [chemical_name] => [weight] => 271.35 [form] => C14H25NO4 [cas] => 247068-83-3 [pslug] => 247068-83-3-1s-3-methyl-1-2s-2-methyloxiranyl-carbonyl-butyl-carbamic-acid-1-1-dimethylethyl-ester-pa3063600 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 30 63600
CAS :
Molecular Formula : C14H25NO4
Molecular Weight : 271.35
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
